ALS lessons learned from other neurological diseases. Parkinson's disease.
Fahn
Stanley
S
Columbia University, New York, New York, USA.
D000690:Amyotrophic Lateral Sclerosis / Q000503:physiopathology*; D000978:Antiparkinson Agents / Q000627:therapeutic use; D001526:Behavioral Symptoms / Q000188:drug therapy / Q000209:etiology; D003067:Coenzymes; D018849:Controlled Clinical Trials as Topic / Q000379:methods; D018450:Disease Progression; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000978:Antiparkinson Agents; D003067:Coenzymes; D018696:Neuroprotective Agents; D014451:Ubiquinone; D007980:Levodopa; C024989:coenzyme Q10